1) section 83 (b), (e) and (g) of the Patents Act, 1970.

 
2) Section 84 of the Patents Act.
3) As per the requirements laid down in Section 83 of the Patents Act,
1970
4) SLP 30145 of 2014, Supreme Court of India.
5)  Section 92 of the Patents Act, 1970
6) Section 92(3) of the Patents Act, 1970
7) Section 100 of the Patents Act, 1970
8) Section 102 of the Patents Act, 1970
9) https://www.fda.gov/media/137564/download
10) Indian Patent No. 332280 titled COMPOUNDS FOR TREATING
FILOVIRIDAE INFECTIONS, granted on 18/02/2020.
11) https://www.gilead.com/purpose/advancing-global-health/covid-
19/voluntary-licensing-agreements-for-remdesivir

12) https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-
the-media-briefing-on-covid-19---11-march-2020

13) https://www.wipo.int/export/sites/www/ip-
competition/en/studies/patent_pools_report.pdf

14) The Open COVID Pledge (April 7, 2020) https://opencovidpledge.org/

15) Open-access letter from CSAs (March 13, 2020) https://cdn.geekwire.com/wp-

content/uploads/2020/03/COVID19-Open-Access-Letter-from-CSAs.Equivalents.pdf